Sprycel

Active Ingredient(s): Dasatinib
FDA Approved: * June 28, 2006
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer

Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).[3] Specifically it is used to treat cases that are Philadelphia chromosome-positive (Ph+).[3] It is taken by mouth.[3] Common adverse effects include low white blood cells, low blood platelets, anemia, swelling, rash, and diarrhea.[3] ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Sprycel BMS;524
Sprycel 70 mg Oral Tablet
NDC: 0003-0524
Labeler:
E.r. Squibb & Sons, L.L.C.
Sprycel BMS;527
Sprycel 20 mg Oral Tablet
NDC: 0003-0527
Labeler:
E.r. Squibb & Sons, L.L.C.
Sprycel BMS;528
Sprycel 50 mg Oral Tablet
NDC: 0003-0528
Labeler:
E.r. Squibb & Sons, L.L.C.
Sprycel BMS100;852
Sprycel 100 mg Oral Tablet
NDC: 0003-0852
Labeler:
E.r. Squibb & Sons, L.L.C.
Sprycel BMS;524
Sprycel 70 mg Oral Tablet
NDC: 54868-5759
Labeler:
Physicians Total Care, Inc.
Sprycel 80 mg Oral Tablet
NDC: 0003-0855
Labeler:
E.r. Squibb & Sons, L.L.C.
Sprycel 140 mg Oral Tablet
NDC: 0003-0857
Labeler:
E.r. Squibb & Sons, L.L.C.

Related Brands

Drugs with the same active ingredients